Tech Focus Asia: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Tech Focus Asia.

Press releases published on May 11, 2026

Kaltura Announces Financial Results for First Quarter 2026
Metagenomi Therapeutics Reports Business Updates and First Quarter 2026 Financial Results
Sana Biotechnology Reports First Quarter 2026 Financial Results and Business Updates
Life360 Reports Record Q1 2026 Results
Elicio Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Updates
Sangamo Therapeutics Announces First Quarter 2026 Earnings Call
Immunovant to Report Financial Results for the Fourth Quarter and Fiscal Year Ended March 31, 2026, and Provide Business Update on Wednesday, May 20, 2026 
Kyntra Bio Reports First Quarter 2026 Financial Results and Provides Business Update
Coherus Oncology Reports First Quarter 2026 Financial Results and Provides Business Update
Eikon Therapeutics Reports First Quarter 2026 Financial Results and Provides Clinical Updates
Aura Biosciences Reports First Quarter 2026 Financial Results and Business Highlights
Aktis Oncology Reports Financial Results and Business Highlights for First Quarter 2026
aTyr Pharma Provides Regulatory and Clinical Update for Efzofitimod in Pulmonary Sarcoidosis Following FDA Type C Meeting
Septerna Highlights Business Progress and Reports First Quarter 2026 Financial Results
Erasca Reports First Quarter 2026 Business Updates and Financial Results
Skye Bioscience Reports First Quarter 2026 Financial Results and Business Update
Ambow Education Announces First Quarter of 2026 Financial Results
FuelSync Fuel Saver: The Smart Plug-In Device That's Changing How Drivers Think About Fuel
Kneat.com Responds to Press Report
ダークホース・コンサルティング・グループと昆拓、細胞・遺伝子治療開発企業向けに中国での臨床開発を加速させる覚書の締結を発表

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Tech Focus Asia

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.